Welcome to our dedicated page for United States Antimony SEC filings (Ticker: UAMY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Antimony tonnage tables, reclamation liabilities, fluctuating smelter yields—United States Antimony’s SEC documents can overwhelm even experienced analysts. Whether you are searching for “United States Antimony SEC filings explained simply” or need the latest “United States Antimony insider trading Form 4 transactions”, the raw EDGAR feed alone rarely answers core valuation questions.
Stock Titan solves this problem with an AI layer built for complex resource companies. Our system scans every 10-K, 10-Q, 8-K and proxy in real time, then delivers plain-English summaries alongside the original text. You’ll see environmental footnotes, mine-life assumptions and segment revenue called out automatically. Need to monitor Form 4 activity? We provide “United States Antimony Form 4 insider transactions real-time” alerts so you learn when executives buy or sell before the market digests the move. Looking for production trends? Our dashboards link the “United States Antimony quarterly earnings report 10-Q filing” to historical ore grades and cash-cost metrics.
Here’s what becomes effortless:
- Compare year-over-year mine output using data extracted from the annual report 10-K simplified
- Track executive stock transactions Form 4 against antimony price swings
- Review proxy statement executive compensation details next to production bonuses
- Decode 8-K material events explained—from furnace shutdowns to offtake agreements
With comprehensive coverage and instant AI commentary, Stock Titan turns hundreds of pages into decisive insight. Stop skimming PDFs and start understanding United States Antimony SEC documents with AI in minutes.
United States Antimony Corp (UAMY) insider award disclosure: Director and EVP Lloyd Bardswich was granted time-based restricted stock units totaling 180,000 shares and stock options covering 225,000 shares on 05/27/2025. The RSUs vest one-third on 05/27/2025 and the remainder in equal annual tranches through 05/27/2027, subject to continued service and shareholder approval of the company's Amended Restated 2023 Equity Incentive Plan. The options carry a $2.57 exercise price and vest upon achievement of specified performance measures at any time during their 10-year term, also subject to continued service and shareholder approval. The Form 4 reports these awards as beneficially owned following the transactions and is signed by Lloyd Joseph Bardswich on 09/18/2025.
United States Antimony Corp (UAMY) prospectus supplement highlights that the company remains in the exploration stage and lists a broad set of operational, regulatory, market, geopolitical and financing risks that could materially affect its business. The disclosure notes concentration risks, fluctuations in antimony and precious metal prices, potential environmental and security issues in Mexico, and cybersecurity and supply-chain concerns. The company also discloses potential stock dilution from outstanding equity awards and several warrant series exercisable at specified prices, and reserves shares under its Equity Incentive Plan.
United States Antimony Corp (UAMY) insider filing: Richard R. Isaak, SVP and Chief Financial Officer, reported awards on May 27, 2025 that were filed on Form 4. He received a time-based restricted stock unit award covering 180,000 common shares that vests one-third each on May 27 of 2025, 2026 and 2027, subject to continued service and shareholder approval of the company’s Amended Restated 2023 Equity Incentive Plan. He also received a stock option covering 200,000 underlying shares with an exercise price of $2.57, vesting upon satisfaction of specified performance measures during the option’s 10-year term and also conditioned on shareholder approval.
John C. Gustavsen, President of the Antimony Division at United States Antimony Corp (UAMY), was granted equity awards on 05/27/2025 consisting of 125,000 restricted stock units (RSUs) and 150,000 stock options. Both grants are contingent on shareholder approval of the Issuer's Amended Restated 2023 Equity Incentive Plan.
The RSUs vest time-based in three equal installments (one-third or 41,667 shares on each of May 27, 2025, 2026 and 2027) subject to continued service and shareholder approval. The stock options vest upon achievement of specified performance measures at any time during the options' 10-year term, subject to continued service and shareholder approval. Following the reported transactions, the filings indicate 0 shares beneficially owned from these awards until vesting/approval conditions are met.
Melissa M. Pagen, SVP of Corporate Development & Government Relations at United States Antimony Corp (UAMY), reported awards granted on 05/27/2025 that are contingent on shareholder approval of the companys Amended Restated 2023 Equity Incentive Plan. The filing shows a time-based RSU award for 100,000 shares vesting one-third on each of May 27, 2026, 2027 and 2028 subject to continued service and plan approval. It also shows a stock option for 150,000 shares with a $2.57 exercise price that vests upon meeting specified performance measures during its 10-year term, also contingent on shareholder approval. The Form 4 is signed 09/15/2025.
The prospectus supplement for United States Antimony Corporation (UAMY) discloses that proceeds to the company after expenses and a credit will be $17,605,000. The document notes it was filed with the SEC on April 18, 2025, and describes that offered debt securities may be sold at a fixed price or prices, at prevailing market prices, at prices related to prevailing market prices, or at negotiated prices. No additional financial metrics, use of proceeds details, maturity, interest rates, or underwriting terms are provided in the excerpt.
FAQ
What is the current stock price of United States Antimony (UAMY)?
What is the market cap of United States Antimony (UAMY)?
